Related Experiment Video
Updated: Sep 8, 2025

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Plasma Metabolomics and Machine Learning Reveals Metabolic Alterations and Diagnostic Biomarkers for Deep Venous
Mukhtar Aliyu1,2, Kun Zhang1,3, Shi-Hao Tang1
1Key Laboratory of Biomedical Information Engineering of Ministry of Education, Key Laboratory of Biology Multi-omics and Diseases in Shaanxi Province Higher Education Institutions, Biomedical Informatics & Genomics Center, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, Shaanxi 710049, P. R. China.
Abstract:
We aimed to explore the metabolic dysregulations and diagnostic biomarkers for post-traumatic deep venous thrombosis (pt-DVT) in hypertensive (HPT) patients after fracture. An untargeted ultraperformance liquid chromatography-mass spectrometry-based metabolomics approach was employed to perform a comprehensive metabolic analysis of plasma samples of 80 patients with post-traumatic deep venous thrombosis and hypertension (pt-DVT&HPT) and 117 patients with hypertension only (HPT). Thirty-seven (37) differential metabolites were identified between pt-DVT&HPT and HPT patients. Purine metabolism, citric acid cycle, sphingolipid metabolism, histidine metabolism, aminoacyl-tRNA biosynthesis, valine, leucine, and isoleucine degradation were the most significantly altered metabolic pathways in pt-DVT in HPT patients. Metabolite-protein interaction network analysis unveils ten (10) proteins/genes that could serve as therapeutic targets. Multivariate methods with Unbiased Variable selection in the R package (MUVR) algorithm identified four metabolites as novel biomarkers for pt-DVT&HPT, and receiver operating characteristics (ROC) analysis showed that a predictive model based on the four biomarkers (l-carnitine, lactic acid, adenine, and l-acetylcarnitine) exhibited better predictive capability for pt-DVT than the D-Dimer. The integration of these diagnostic biomarkers and D-Dimer increased its diagnostic potential. The generalization ability of this biomarker panel was validated in an independent cohort. This study contributed to our understanding of metabolic alterations associated with pt-DVT and paved the way for early diagnosis of pt-DVT in HPT patients.
More Related Videos
05:30Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care